Stat Health, a Boston, MA-based digital health company, raised $5.1M in Seed funding.
The round saw participation from J2 Ventures, BonAngels Venture Partners, and a diverse group of angel investors. It has also received grant funding from the U.S. Air Force.
The company intends to use the funds to understand symptoms that occur upon standing, such as dizziness, brain fog, headaches, fainting, and fatigue.
Founded in 2020 and led by CEO Daniel Lee and COO Paul Jin, Stat Health is a digital health company that has emerged from stealth to introduce a 24/7 in-ear wearable that measures blood flow to the head to better understand symptoms such as dizziness, brain fog, headaches, fainting, and fatigue that occur upon standing. Clinically tested at Johns Hopkins and peer-reviewed in the March 2023 issue of Journal of the American College of Cardiology (JACC), the device has been shown to predict fainting minutes before it happens. In addition to the advanced optical sensors, the device incorporates an accelerometer, a pressure sensor, temperature sensors, AI edge computing, multi-day battery life, and a micro solar panel. It can be worn in-ear 24/7 — it co-exists with more than 90% of devices that go in/around the ear, and can be left in while sleeping and showering.
The company is now taking pre-order reservation deposits on their newly-launched website, www.stat-health.com, offering VIP early adopter perks including early access, beta test opportunities, and more.
